REBECCA ZIMMERMAN: Open Payments
NPI 1356945075 · ELKHART, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$778 in 33 payments from 14 companies in 2025. Trend: 2023 $1,106 · 2024 $1,572 · 2025 $778
Food & beverage: $778
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $190 |
| Alnylam Pharmaceuticals Inc. | 6 | $161 |
| AtriCure, Inc. | 1 | $90 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| Abbott Laboratories | 2 | $45 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $35 |
| Boston Scientific Corporation | 1 | $34 |
| PFIZER INC. | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| E.R. Squibb & Sons, L.L.C. | 2 | $28 |
Products named: ONPATTRO, VERQUVO, ATRICLIP LAA EXCLUSION SYSTEM, Kerendia, ELIQUIS, CARDIOMEMS, CAPVAXIVE, LifeVest.
Industry payments across IN — which companies pay providers there.
